TrialRMD open2026

First-in-human (phase I) trial of SOL-116, a humanised IgG4 monoclonal antibody targeting bile salt-stimulated lipase, in healthy participants and rheumatoid arthritis patients.

Anouk C Meijs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.